| Absolute quantification of cell-free microRNAs in cancer patients M Ferracin, L Lupini, I Salamon, E Saccenti, MV Zanzi, A Rocchi, ... Oncotarget 6 (16), 14545, 2015 | 142 | 2015 |
| The long noncoding RNA landscape in cardiovascular disease: a brief update I Salamon, GS Jotti, G Condorelli Current opinion in cardiology 33 (3), 282-289, 2018 | 28 | 2018 |
| Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer G Durante, E Broseghini, F Comito, M Naddeo, M Milani, I Salamon, ... Expert review of molecular diagnostics 22 (3), 305-318, 2022 | 18 | 2022 |
| An autofluorescence-based method for the isolation of highly purified ventricular cardiomyocytes V Larcher, P Kunderfranco, M Vacchiano, P Carullo, M Erreni, I Salamon, ... Cardiovascular Research 114 (3), 409-416, 2018 | 15 | 2018 |
| ARID1A in cancer: Friend or foe? B Fontana, G Gallerani, I Salamon, I Pace, R Roncarati, M Ferracin Frontiers in Oncology 13, 1136248, 2023 | 14 | 2023 |
| Genetic characterization of cancer of unknown primary using liquid biopsy approaches N Laprovitera, I Salamon, F Gelsomino, E Porcellini, M Riefolo, M Garonzi, ... Frontiers in Cell and Developmental Biology 9, 666156, 2021 | 14 | 2021 |
| Divergent transcription of the Nkx2-5 locus generates two enhancer RNAs with opposing functions I Salamon, S Serio, S Bianco, C Pagiatakis, S Crasto, AM Chiariello, ... Iscience 23 (9), 2020 | 11 | 2020 |
| Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR M Ferracin, I Salamon, L Lupini, E Miotto, S Sabbioni, M Negrini JoVE (Journal of Visualized Experiments), e54102, 2016 | 10 | 2016 |
| Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease I Salamon, E Biagini, P Kunderfranco, R Roncarati, M Ferracin, N Taglieri, ... Cell Death & Disease 12 (12), 1150, 2021 | 8 | 2021 |
| Correlations between cardiac magnetic resonance and myocardial histologic findings in Fabry disease R Ditaranto, O Leone, L Lovato, F Niro, G Cenacchi, V Papa, C Baldovini, ... Cardiovascular Imaging 16 (12), 1629-1632, 2023 | 2 | 2023 |
| The Non-Coding RNA Journal Club: Highlights on Recent Papers—9 N Renwick, A El-Osta, I Salamon, E Broseghini, M Ferracin, L Poliseno, ... Non-coding RNA 7 (3), 58, 2021 | 2 | 2021 |
| Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking V Parisi, R Baldassarre, V Ferrara, R Ditaranto, F Barlocco, R Lillo, F Re, ... Frontiers in Cardiovascular Medicine 10, 1184361, 2023 | 1 | 2023 |
| How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer M Ferracin, L Lupini, I Salamon, E Saccenti, B Zagatti, A Mangolini, ... Cancer Research 75 (15_Supplement), 3964-3964, 2015 | 1 | 2015 |
| Extrachromosomal FGFR2 is delivered in extracellular vesicles in two models of cancer of unknown primary I Salamon, G Storci, B Fontana, S Serravalle, G Gallerani, R Roncarati, ... Cancer Research 84 (6_Supplement), 6957-6957, 2024 | | 2024 |
| OPEN ACCESS EDITED BY A Kirmizis, I De La Serna, M Ferracin, R Roncarati, B Fontana, G Gallerani, ... Women in Cancer Molecular Targets and Therapeutics, Volume II: 2022, 298, 2023 | | 2023 |
| Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary A Cavazzoni, I Salamon, C Fumarola, G Gallerani, N Laprovitera, ... Molecular Therapy, 2023 | | 2023 |
| Cancer of Unknown Primary: novel therapeutic opportunities from patient-derived cell cultures and in vivo models N Laprovitera, C Fumarola, E Porcellini, S Cairo, G Gallerani, ... Cancer Research 81 (13_Supplement), 3011-3011, 2021 | | 2021 |
| IRENEs: new players in the epigenetic control of Nkx2-5 in the heart I Salamon Humanitas University, 2019 | | 2019 |
| An Autofluorescence-based Method for the Isolation Of Highly Purified Cardiac Ventriculocytes V Larcher, A Anselmo, P Kunderfranco, I Salamon, P Carullo, ... Circulation 136 (suppl_1), A20023-A20023, 2017 | | 2017 |
